首页> 外文期刊>Epilepsy research >A system of equations to approximate the pharmacokinetic parameters of lacosamide at steady state from one plasma sample
【24h】

A system of equations to approximate the pharmacokinetic parameters of lacosamide at steady state from one plasma sample

机译:一个方程组,用于从一个血浆样品中近似估算处于稳态的拉考酰胺的药代动力学参数

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: Frequent plasma sampling to monitor pharmacokinetic (PK) profile of antiepileptic drugs (AEDs), is invasive, costly and time consuming. For drugs with a well-defined PK profile, such as AED lacosamide, equations can accurately approximate PK parameters from one steady-state plasma sample. Methods: Equations were derived to approximate steady-state peak and trough lacosamide plasma concentrations (Cpeak,ss and Ctrough,ss, respectively) and area under concentration-time curve during dosing interval (AUCτ,ss) from one plasma sample. Lacosamide (ka: ~2h-1; ke: ~0.05h-1, corresponding to half-life of 13h) was calculated to reach Cpeak,ss after ~1h (tmax,ss). Equations were validated by comparing approximations to reference PK parameters obtained from single plasma samples drawn 3-12h following lacosamide administration, using data from double-blind, placebo-controlled, parallel-group PK study. Values of relative bias (accuracy) between -15% and +15%, and root mean square error (RMSE) values ≤15% (precision) were considered acceptable for validation. Results: Thirty-five healthy subjects (12 young males; 11 elderly males, 12 elderly females) received lacosamide 100mg/day for 4.5 days. Equation-derived PK values were compared to reference mean Cpeak,ss, Ctrough,ss and AUCτ,ss values. Equation-derived PK data had a precision of 6.2% and accuracy of -8.0%, 2.9%, and -0.11%, respectively. Equation-derived versus reference PK values for individual samples obtained 3-12h after lacosamide administration showed correlation (R2) range of 0.88-0.97 for AUCτ,ss. Correlation range for Cpeak,ss and Ctrough,ss was 0.65-0.87. Error analyses for individual sample comparisons were independent of time. Conclusion: Derived equations approximated lacosamide Cpeak,ss, Ctrough,ss and AUCτ,ss using one steady-state plasma sample within validation range. Approximated PK parameters were within accepted validation criteria when compared to reference PK values.
机译:目的:经常进行血浆采样以监测抗癫痫药物(AED)的药代动力学(PK)情况,这是侵入性的,昂贵且耗时的。对于具有明确定义的PK曲线的药物(例如AED拉可酰胺),方程式可以从一个稳态血浆样品中准确估算PK参数。方法:推导了方程,以近似于一个血浆样品在给药间隔期间的稳态峰值和谷氨酸酰胺血浆浓度(分别为Cpeak,ss和Ctrough,ss)以及浓度-时间曲线下的面积。计算出Lacosamide(ka:〜2h-1; ke:〜0.05h-1,对应于13h的半衰期),在〜1h(tmax,ss)后达到Cpeak,ss。使用双盲,安慰剂对照,平行组PK研究的数据,通过比较拉考沙酰胺给药3-12h后从单个血浆样品中获得的参考PK参数的近似值,来验证方程式。相对偏差(准确性)的值介于-15%和+ 15%之间,并且均方根误差(RMSE)值≤15%(精度)被认为可以接受验证。结果:35名健康受试者(男12例;男11例;女12例)接受拉考酰胺100mg /天治疗4.5天。将公式得出的PK值与参考平均值Cpeak,ss,Ctrough,ss和AUCτ,ss值进行比较。方程派生的PK数据的精度分别为6.2%和-8.0%,2.9%和-0.11%。拉考酰胺给药后3-12h获得的各个样品的方程派生PK值与参考PK值的相关性(R2)范围为AUCτ,ss 0.88-0.97。 Cpeak,ss和Ctrough,ss的相关范围是0.65-0.87。各个样品比较的误差分析与时间无关。结论:在验证范围内,使用一个稳态血浆样品,得出的方程式近似于拉考酰胺Cpeak,ss,Ctrough,ss和AUCτ,ss。与参考PK值相比时,大约PK参数在可接受的验证标准内。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号